Effectiveness of Shared Decision Making(SDM)on Patients With Poor Control Type 2 Diabetes

NCT07810647 — Not applicable, Completed, 70 participants, Fooyin University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07810647, acronym SDM
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, prevention
Enrollment70 (Actual)
SponsorFooyin University (Other)
ConditionsDiabetes Mellitus, Type 2
InterventionsSDM (Behavioral)
Datesstart 2020-05-12, primary completion 2020-10-30, completion 2021-06-30, first posted 2026-09-09, last updated 2026-09-09
Locations1 site in Taiwan

Related Papers Related Patents Related Grants Related Experts
All trials for Diabetes Mellitus, Type 2 All trials of SDM

-Summary

The study is a pilot study, using a convenient sampling method, targeting at outpatient patients with type 2 diabetes who participate in the diabetes co-care program and poor blood sugar control as the research subjects, and randomly assigned. The number of samples is expected to receive 30 patients in each group. The attrition rate estimates about 20%, so there should be 76 people in total, and 38 people in each group. The experimental group was involved in SDM health education; the control group was involved in routine health education. After the implementation of the measures, the self-efficacy and health promotion behavior changes of the two groups and the effectiveness of disease control (glycated hemoglobin, body mass index, waist circumference) were tracked.

Expand all sections  ·  Collapse all

+Detailed description

Background Diabetes and hyperglycemia not only increase the risk of complications of cardiovascular disease and lead to a situation involving exposure to danger of death. Meanwhile, the patient's self-management is one of the key factors affecting the quality control of blood sugar. Thereby, Shared Decision Making (SDM) is a patient-centered medical implementation method that healthcare professionals and patients jointly participate in treatment decision-making to reach a consensus, which can stimulate the health care ability of participants to achieve treatment goals.

Purpose: This research aims to implement the SDM model based on self-efficacy theory through individualized decision-making to strengthen the behavioral motivation of diabetic patients and finally, to improve the patient's health promotion behavior and the effectiveness of blood sugar control.

Method: Study Type: Interventional Actual Enrollment:76 participants Allocation:Randomized Intervention Model:Parallel Assignment Masking:Single(Participant)

Expected results:

It is hoped that the implementation of SDM model will be used to strengthen the behavioral motivation of diabetic patients through individualized decision-making, and to confirm whether it can effectively improve the patient's health behavior and the effectiveness of disease control.

+Arms and interventions

ArmTypeInterventionsDescription
Control group:as usual careNo interventionThe control group received as usual care.
Experimental group:The intervention of SDMExperimentalBehavioral: SDMThe experimental group received the intervention of SDM 3 times for 3 months,
  • SDM (Behavioral): The experimental group received the intervention of SDM 3times/month for 3months, then follow the health promotion behavior compliance by phone once a month.

+Outcome measures

Primary outcomes

  • Diabetes self-efficacy scale [Pre-test (baseline)]: assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
  • Diabetes self-efficacy scale [1 months after intervnetion]: assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
  • Diabetes self-efficacy scale [3 months after intervnetion]: assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
  • Diabetes health literacy scale [Pre-test (baseline)]: A disease-specific scale to measure functional, communicative and critical health literacy in primary care
  • Diabetes health literacy scale [3 months after intervnetion]: A disease-specific scale to measure functional, communicative and critical health literacy in primary care
  • Diabetes health promotion scale [Pre-test (baseline)]: A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
  • Diabetes health promotion scale [1 months after intervnetion]: A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
  • Diabetes health promotion scale [3 months after intervnetion]: A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
  • Hemoglobin A1C (HbA1c) Test [3 months after intervnetion]: An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months.
  • Hemoglobin A1C (HbA1c) Test [Pre-test (baseline)]: An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months

+Eligibility

Sex: All, ages: 20 Years to any

Inclusion Criteria:

* Aged>20y/o
* Diagnosed by a physician as type 2 diabetes
* The Diabetes Participated in the Diabetes Shared Care Network
* Glycosylated hemoglobin (A1C)> 7.5%
* Can communicate in Chinese or Taiwanese.

Exclusion Criteria:

* People with mental or cognitive impairment who cannot communicate
* Health Literacy score lower than 6 points

+Locations (1)

FacilityCityCountryStatus
An Nan Hospition-China Medical UniversityTainan, TaiwanTaiwan